PDCD1 and melanoma: Our results show that tumor growth could be delayed when checkpoint blockade antibodies against programmed cell death protein-1 (PD-1) and T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) were combined with a regimen that enhanced DC numbers and functionality, confirming the importance of DC for successful immunotherapy in melanoma.